Table of Contents

GlaxoSmithKline PLC has agreed to pay up to $2.2 billion to settle more than 90% of pending U.S. state court product liability cases involving Zantac. These lawsuits claim that a discontinued version of the heartburn medication contained NDMA, a probable human carcinogen, which led to cancer in numerous users.

This settlement marks a significant step in addressing the claims of individuals and families affected by Zantac-related health issues. If you believe Zantac may have impacted your health, now is the time to consult with experienced Zantac lawsuit attorneys to understand your legal options.

Enter a 10-digit phone number with digits only (e.g., 1234567890)

By clicking the ‘Get a Free Review’ button, I hereby grant consent to be contacted at the phone number above for marketing purposes by Tort Advisor and its partners. I understand this may include an automated calling system, artificial voice, pre-recorded message, or an SMS text message. I consent even if my phone number provided is registered on the Federal or State ‘Do Not Call Registry’. I acknowledge that standard message and data rates may apply. Message frequency varies. Text HELP for help. Text STOP to cancel. Clicking ‘Get a Free Review’ constitutes my electronic signature for authorization to be contacted and my agreement to the Terms and Conditions and [Privacy Policy]. This authorization is not required to qualify for, purchase goods, or receive services.

Partners Off-Canvas (Hidden)